Literature DB >> 19833907

The relationship between hemoglobin levels and endothelial functions in diabetes mellitus.

Alper Sonmez1, Mahmut Ilker Yilmaz, Mutlu Saglam, Selim Kilic, Tayfun Eyileten, Gokhan Uckaya, Kayser Caglar, Yusuf Oguz, Abdulgaffar Vural, Mujdat Yenicesu, Mustafa Kutlu, Can Kinalp, Carmine Zoccali.   

Abstract

BACKGROUND AND OBJECTIVES: Hemoglobin (Hb) is the main carrier and buffer of nitric oxide. Evidence has been produced that Hb concentration is inversely related with endothelial function in human diseases. Testing whether this association exists also in diabetic patients stage 1 to 2 chronic kidney disease (CKD) is important because anemia in these patients starts at an earlier stage than in other renal diseases. The relationship was investigated between Hb and flow-mediated dilation (FMD) levels of the patients with diabetic nephropathy in a cross-sectional design. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Eighty-nine diabetics with mild to moderate proteinuria and normal to mildly reduced GFR who were normotensive, nondyslipidemic, and cardiovascular-events free were enrolled. None of the patients was taking metformin or renin-angiotensin system blockers.
RESULTS: FMD was inversely related with Hb levels. Furthermore, there was an inverse link between proteinuria and FMD. However, further analysis of this association showed that the FMD-proteinuria link was confined to patients with proteinuria exceeding 150 mg/d, while no such association existed in patients with proteinuria <150 mg/d. Adjustment of the Hb-FMD relationship for pertinent Framingham risk factors, proteinuria, homeostasis model assessment (HOMA) index, and GFR levels had a modest influence on this association, which remained significant.
CONCLUSIONS: Endothelial function is inversely associated with Hb levels in diabetic patients with stage 1 to 2 CKD, and proteinuria is an effect modifier of this association. Overall, the observations of this study generate the hypothesis that proteinuria exposes a situation wherein Hb may limit the endothelium-mediated vasoregulation in diabetes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19833907      PMCID: PMC2801645          DOI: 10.2215/CJN.05080709

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  21 in total

1.  The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine.

Authors:  Mahmut Ilker Yilmaz; Mutlu Saglam; Kayser Caglar; Erdinc Cakir; Alper Sonmez; Taner Ozgurtas; Ahmet Aydin; Tayfun Eyileten; Omer Ozcan; Cengizhan Acikel; Mustafa Tasar; Gultekin Genctoy; Kemal Erbil; Abdulgaffar Vural; Carmine Zoccali
Journal:  Am J Kidney Dis       Date:  2006-01       Impact factor: 8.860

2.  Endothelial dysfunction in CKD: a new player in town?

Authors:  Carmine Zoccali
Journal:  Nephrol Dial Transplant       Date:  2008-01-04       Impact factor: 5.992

3.  S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control.

Authors:  L Jia; C Bonaventura; J Bonaventura; J S Stamler
Journal:  Nature       Date:  1996-03-21       Impact factor: 49.962

4.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

5.  ADMA, proteinuria, and insulin resistance in non-diabetic stage I chronic kidney disease.

Authors:  K Caglar; M I Yilmaz; A Sonmez; E Cakir; A Kaya; C Acikel; T Eyileten; M Yenicesu; Y Oguz; C Bilgi; C Oktenli; A Vural; C Zoccali
Journal:  Kidney Int       Date:  2006-07-05       Impact factor: 10.612

6.  Abnormal metabolic fate of nitric oxide in Type I diabetes mellitus.

Authors:  A B Milsom; C J H Jones; J Goodfellow; M P Frenneaux; J R Peters; P E James
Journal:  Diabetologia       Date:  2002-10-12       Impact factor: 10.122

7.  A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group.

Authors:  A S Levey; J P Bosch; J B Lewis; T Greene; N Rogers; D Roth
Journal:  Ann Intern Med       Date:  1999-03-16       Impact factor: 25.391

Review 8.  Chemical physiology of blood flow regulation by red blood cells: the role of nitric oxide and S-nitrosohemoglobin.

Authors:  David J Singel; Jonathan S Stamler
Journal:  Annu Rev Physiol       Date:  2005       Impact factor: 19.318

9.  Hemoglobin is inversely related to flow-mediated dilatation in chronic kidney disease.

Authors:  Mahmut I Yilmaz; Alper Sonmez; Mutlu Saglam; Mahir Gulec; Selim Kilic; Tayfun Eyileten; Kayser Caglar; Yusuf Oguz; Abdulgaffar Vural; Mujdat Yenicesu; Carmine Zoccali
Journal:  Kidney Int       Date:  2009-03-04       Impact factor: 10.612

Review 10.  Anemia and anemia correction: surrogate markers or causes of morbidity in chronic kidney disease?

Authors:  Nosratola D Vaziri
Journal:  Nat Clin Pract Nephrol       Date:  2008-06-10
View more
  12 in total

1.  Estimated GFR, albuminuria, and complications of chronic kidney disease.

Authors:  Lesley A Inker; Josef Coresh; Andrew S Levey; Marcello Tonelli; Paul Muntner
Journal:  J Am Soc Nephrol       Date:  2011-09-30       Impact factor: 10.121

2.  Hemoglobin concentration and incident metabolic syndrome: a population-based large-scale cohort study.

Authors:  Yoshitaka Hashimoto; Muhei Tanaka; Toshihiro Kimura; Noriyuki Kitagawa; Masahide Hamaguchi; Mai Asano; Masahiro Yamazaki; Yohei Oda; Hitoshi Toda; Naoto Nakamura; Michiaki Fukui
Journal:  Endocrine       Date:  2015-04-12       Impact factor: 3.633

3.  Flow-mediated vasodilation in end-stage renal disease.

Authors:  Francis H Verbeke; Bruno Pannier; Alain P Guérin; Pierre Boutouyrie; Stephane Laurent; Gérard M London
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 8.237

4.  Hematological parameters are associated with metabolic syndrome in Japanese community-dwelling persons.

Authors:  Ryuichi Kawamoto; Yasuharu Tabara; Katsuhiko Kohara; Tetsuro Miki; Tomo Kusunoki; Masanori Abe; Tateaki Katoh
Journal:  Endocrine       Date:  2013-01-10       Impact factor: 3.633

5.  Metabolic syndrome and its components associated with endothelial dysfunction in chronic kidney disease patients.

Authors:  Qiong Bai; Xuan Lai; Ai-Hua Zhang; Xin-Hong Lu; Shun-Li Tian; Min-Hua Fan; Yue Wang; Tao Wang
Journal:  Vasc Health Risk Manag       Date:  2012-01-06

6.  Association between neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and diabetic retinopathy among diabetic patients without a related family history.

Authors:  Jin-Rui Wang; Zhongli Chen; Ke Yang; Hui-Jun Yang; Wen-Yu Tao; Yi-Ping Li; Ze-Jia Jiang; Chao-Fang Bai; Yue-Chuan Yin; Jian-Mei Duan; Yuan-Yuan Zhou; Xin-Qian Geng; Ying Yang
Journal:  Diabetol Metab Syndr       Date:  2020-07-02       Impact factor: 3.320

7.  Decreased GFR and its joint association with type 2 diabetes and hypertension with prevalence and severity of carotid plaque in a community population in China.

Authors:  Qianzi Che; Ying Yang; Guanliang Cheng; Jia Jia; Fangfang Fan; Jianping Li; Yong Huo; Dafang Chen; Yan Zhang
Journal:  Diabetes Metab Syndr Obes       Date:  2019-07-26       Impact factor: 3.168

8.  High hemoglobin levels are associated with decreased risk of diabetic retinopathy in Korean type 2 diabetes.

Authors:  Min-Kyung Lee; Kyung-Do Han; Jae-Hyuk Lee; Seo-Young Sohn; Jee-Sun Jeong; Mee-Kyoung Kim; Ki-Hyun Baek; Ki-Ho Song; Hyuk-Sang Kwon
Journal:  Sci Rep       Date:  2018-04-03       Impact factor: 4.379

9.  Exercise training and endothelial function in patients with type 2 diabetes: a meta-analysis.

Authors:  Shanhu Qiu; Xue Cai; Han Yin; Zilin Sun; Martina Zügel; Jürgen Michael Steinacker; Uwe Schumann
Journal:  Cardiovasc Diabetol       Date:  2018-05-02       Impact factor: 9.951

10.  Association between Hemoglobin Levels and Colorectal Polyps in Asymptomatic Chinese Adults.

Authors:  Chao Shen; Xiaoying Shi; Maram Al-Ashoor; Chengfu Xu
Journal:  Gastroenterol Res Pract       Date:  2020-01-18       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.